US Patent Issued to DENALI THERAPEUTICS on July 15 for "LRRK2 inhibitors and methods of making and using thereof" (California Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,896, issued on July 15, was assigned to DENALI THERAPEUTICS INC. (South San Francisco, Calif.).

"LRRK2 inhibitors and methods of making and using thereof" was invented by Javier de Vicente Fidalgo (Foster City, Calif.), Anthony A. Estrada (San Mateo, Calif.), Jianwen A. Feng (San Mateo, Calif.) and Zachary K. Sweeney (Redwood City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates generally to LRRK2 inhibitors, or a pharmaceutically acceptable salt, isotopically enriched analog, tautomer, stereoisomer, mixture of stereoisomers, prodrug, or pharmaceutical composition thereof, and methods of making and using thereof....